4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000120
Chief Medical Officer sold 30,000 shares at $30.48 ($914,400)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-04 | Sale : show line 1 in the form 10b5-1 | −30,000 | $30.48 | $914,400 | 54,645 | D |
| Open-market sales · 30,000 sh · avg $30.48 · $914,400 | ||||||
Loading xslF345X06/wk-form4_1786047196.xml…